These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34422720)
1. A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells El-Soussi S; Hanna R; Semaan H; Khater AR; Abdallah J; Abou-Kheir W; Abou-Antoun T Front Pediatr; 2021; 9():693145. PubMed ID: 34422720 [TBL] [Abstract][Full Text] [Related]
2. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration. Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367 [TBL] [Abstract][Full Text] [Related]
3. A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells. Hanna R; Abdallah J; Abou-Antoun T Front Oncol; 2020; 10():624560. PubMed ID: 33569349 [TBL] [Abstract][Full Text] [Related]
4. Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells. Zhang Y; Tapinos N; Lulla R; El-Deiry WS Am J Cancer Res; 2024; 14(5):2453-2464. PubMed ID: 38859853 [TBL] [Abstract][Full Text] [Related]
5. Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors. Chang WI; Honeyman JN; Zhang J; Lin C; Sharma A; Zhou L; Oliveira J; Tapinos N; Lulla RR; Prabhu VV; El-Deiry WS Am J Cancer Res; 2023; 13(12):6241-6255. PubMed ID: 38187038 [TBL] [Abstract][Full Text] [Related]
6. ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer. Tucker K; Yin Y; Staley SA; Zhao Z; Fang Z; Fan Y; Zhang X; Suo H; Sun W; Prabhu VV; Allen JE; Zhou C; Bae-Jump VL Am J Cancer Res; 2022; 12(2):521-536. PubMed ID: 35261784 [TBL] [Abstract][Full Text] [Related]
7. L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression. Rached J; Nasr Z; Abdallah J; Abou-Antoun T Int J Oncol; 2016 Oct; 49(4):1722-30. PubMed ID: 27432152 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212. Wagner J; Kline CL; Ralff MD; Lev A; Lulla A; Zhou L; Olson GL; Nallaganchu BR; Benes CH; Allen JE; Prabhu VV; Stogniew M; Oster W; El-Deiry WS Cell Cycle; 2017 Oct; 16(19):1790-1799. PubMed ID: 28489985 [TBL] [Abstract][Full Text] [Related]
9. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[ Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970 [TBL] [Abstract][Full Text] [Related]
10. Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer. Staley A; Tucker K; Yin Y; Zhang X; Fan Y; Zhang Y; Fang Z; Sun W; Suo H; Zhao X; Zhao Z; Prabhu VV; Allen JE; Zhou C; Bae-Jump VL Am J Cancer Res; 2021; 11(11):5374-5387. PubMed ID: 34873466 [TBL] [Abstract][Full Text] [Related]
11. ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN. Wu JC; Huang CC; Wang PW; Chen TY; Hsu WM; Chuang JH; Chuang HC Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675163 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines. Purcell C; Srinivasan PR; Pinho-Schwermann M; MacDonald WJ; Ding E; El-Deiry WS bioRxiv; 2024 Aug; ():. PubMed ID: 39257809 [TBL] [Abstract][Full Text] [Related]
13. Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis. Borsuk R; Zhou L; Chang WI; Zhang Y; Sharma A; Prabhu VV; Tapinos N; Lulla RR; El-Deiry WS Am J Cancer Res; 2021; 11(9):4607-4623. PubMed ID: 34659909 [TBL] [Abstract][Full Text] [Related]
14. Combination bromo- and extraterminal domain and poly (ADP-ribose) polymerase inhibition synergistically enhances DNA damage and inhibits neuroblastoma tumorigenesis. Jacobson JC; Qiao J; Clark RA; Chung DH Discov Oncol; 2022 Oct; 13(1):103. PubMed ID: 36227363 [TBL] [Abstract][Full Text] [Related]
15. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma. Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732 [TBL] [Abstract][Full Text] [Related]
16. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase. Veas-Perez de Tudela M; Delgado-Esteban M; Cuende J; Bolaños JP; Almeida A J Neurochem; 2010 May; 113(4):819-25. PubMed ID: 20180881 [TBL] [Abstract][Full Text] [Related]
17. High mobility group A1 is a molecular target for MYCN in human neuroblastoma. Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307 [TBL] [Abstract][Full Text] [Related]
18. ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer Zhang Y; Huang Y; Yin Y; Fan Y; Sun W; Zhao X; Tucker K; Staley A; Paraghamian S; Hawkins G; Prabhu V; Allen JE; Zhou C; Bae-Jump V Front Oncol; 2020; 10():577141. PubMed ID: 33194693 [TBL] [Abstract][Full Text] [Related]
19. JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells. Kuo YT; Liu YL; Adebayo BO; Shih PH; Lee WH; Wang LS; Liao YF; Hsu WM; Yeh CT; Lin CM PLoS One; 2015; 10(5):e0125343. PubMed ID: 25951238 [TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line. Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]